Domain | Risk factor | No. of papers | No. of models | No. models which were significant | % models which were significant | Increased mortality risk | Decreased mortality risk |
---|---|---|---|---|---|---|---|
Demographics/ lifestyle | Increasing age | 37 [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71] | 64 | 51 | 79.7% | 100% [36, 40,41,42,43,44,45,46,47,48, 50,51,52,53,54,55,56,57,58, 61,62,63,64,65,66, 68, 70, 71] | - |
Demographics/ lifestyle | Female, gender | 20 [39, 42,43,44,45,46,47,48, 50,51,52,53, 56, 57, 61, 62, 66, 67, 72, 73] | 32 | 13 | 40.6% | - | |
Comorbidities | Presence of diabetes | 19 [36, 39, 42,43,44,45,46,47, 49, 50, 55,56,57, 66, 67, 69,70,71, 74] | 24 | 11 | 45.8% | 9.1% [46] | |
Comorbidities | Presence of heart conditions | 18 [36, 37, 42,43,44,45,46,47, 49, 50, 55, 64, 68, 70, 71, 74,75,76] | 27 | 20 | 74.1% | 5% [68] | |
Biomarkers | Decreasing albumin levels | 19 [44,45,46,47,48,49, 54,55,56, 61, 64, 66, 67, 71, 73, 77,78,79,80] | 27 | 20 | 74.1% | - | |
Biomarkers | Increasing C-reactive protein | 27 | 22 | 81.5% | - | ||
Biomarkers | Increasing haemoglobin levels | 29 | 11 | 37.9% | - | ||
Frailty status | Lower body mass index | 23 | 16 | 69.6% | |||
Frailty status | Poor functional status | 20 | 15 | 75.0% | - |